SCHEMBL30180642

SCHEMBL30180642

CCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCN1C(=O)C=CC1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.41
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39
TSHR P16473 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
HSD17B10 Q99714 1/20 0.37
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
BLM P54132 1/20 0.36
WRN Q14191 1/20 0.36
HIF1A Q16665 1/20 0.36
AKT1 P31749 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
NAMPT P43490 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24916800 0.92 MGLL (0.47) MGLLSMN1; SMN2GSK3AGSK3BALDH1A1
SCHEMBL12181821 0.92 MGLL (0.47) MGLLSMN1; SMN2GSK3AGSK3BALDH1A1
SCHEMBL21648869 0.90 MGLL (0.45) MGLLSMN1; SMN2GSK3AGSK3BALDH1A1
SCHEMBL277801 0.90 SMN1; SMN2 (0.42) MGLLSMN1; SMN2GSK3AGSK3BTSHR
SCHEMBL20272155 0.90 MGLL (0.45) MGLLSMN1; SMN2GSK3AGSK3BALDH1A1
SCHEMBL15143431 0.89 MGLL (0.47) MGLLSMN1; SMN2GSK3AGSK3BTSHR
SCHEMBL16329201 0.89 MGLL (0.47) MGLLSMN1; SMN2GSK3AGSK3BTSHR
SCHEMBL24136290 0.89 MGLL (0.47) MGLLSMN1; SMN2GSK3AGSK3BTSHR
SCHEMBL13311294 0.89 MGLL (0.47) MGLLSMN1; SMN2GSK3AGSK3BTSHR
SCHEMBL24591874 0.89 MGLL (0.47) MGLLSMN1; SMN2GSK3AGSK3BTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4370157-A1 ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2024-05-22 EP disclosed
WO-2023288033-A1 ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2023-01-19 WO disclosed